The Health Care M&A Monthly: The Premiums They Paid, Part II —

Biotechnology Premiums For The Past Five Years With this second installment, we continue our series on premiums paid in the acquisition of publicly traded health care companies over the period 2007-2011. We follow the methodology used in our analysis of premiums paid...